Most Popular Blogs of 2019
What did the research community enjoy most in 2019? Read Advarra's most popular blogs from industry experts and IRB members here.
Reporting to the IRB: What NOT to Report
Reportable events can be tricky: according to the regulations, not every unanticipated event should be submitted to the IRB.
Reporting to the IRB: Investigator Noncompliance
Uncover what the regulations say about IRB reporting requirements and how Advarra has addressed some of the undefined gray areas around noncompliance.
Making Sense of the New HUD Guidance
Understand how the new HUD guidance clarifies responsibilites of the IRB and institutions, while widening the access of small communities to HUDs.
Should Social Media Be Part of Your Research Toolbox?
Social media has emerged as a valuable tool for diverse stakeholders across the research community. Learn about the risks and benefits in this article.
A Tale of Two Sites: The Power of Integrated Research Administration
Learn how institutions attract more studies from the the tale of two sites: one with an integrated research administration, and one without.
Reflections on SCDM 2019: Technology’s Role in Transforming Clinical Data Management
Advarra attended the SCDM Annual Conference earlier this month, and took the time to reflect on the growth of the clinical data management domain.
Reporting to the IRB: Unanticipated Device Effects (UADEs) in Medical Device Studies
What do the regulations say about unanticipated device effects and IRB reporting requirements? In this blog, Advarra addresses some frustrating gray areas.
How Centralized IBC Review Can Benefit Gene Therapy Research
Gene therapy research is at the forefront of a coming boom in the clinical setting. Understand the growth, risks, and regulatory requirements here.
Advarra Acquires Forte:
What You Need to Know
On September 5, 2019, Advarra announced its intent to acquire Forte.
Compensating Clinical Trial Participants: The Basics
Participant compensation is often a complicated matter. This blog will shed light on what an IRB considers during its review.
What Is a Screening Consent?
Study-specific screening consent is a subtype of informed consent, which ensures a research participant understands of the research and its risks.